Abstract
RNA silencing negatively regulates gene expression at transcriptional and posttranscriptional levels, guided by small RNA molecules. It modulates core regulatory pathways across the eukaryotes, such as developmental processes or stress responses. The widespread existence of this phenomenon and the key pathways regulated have led to the development of a new technology based on the modification of gene expression, which has been applied successfully in different areas such as medicine or agriculture. Here we review the most important patents related to RNA silencing across the life kingdoms, including biotechnological applications into medicine, crop science and bioengineering.
Keywords: Chlamydomonas, disease therapy, fungi, gene therapy, microRNA, patent, plant biotechnology, RNA silencing, sRNA, post-transcriptional gene silencing in plants, lymphoblastic leukaemia, anti-miRNA oligonucleotides (AMOs), Kaposi, ’, s sarcoma-associated herpesvirus (KSHV), respiratory syncytial virus (RSV), parainfluenza virus (PIV)
Recent Patents on Biotechnology
Title: Bioengineering RNA Silencing Across the Life Kingdoms
Volume: 5 Issue: 2
Author(s): R. Alvarez-Fernandez, S. Lopez-Gomollon, A. F. Lopez-Martinez and F. E. Nicolas
Affiliation:
Keywords: Chlamydomonas, disease therapy, fungi, gene therapy, microRNA, patent, plant biotechnology, RNA silencing, sRNA, post-transcriptional gene silencing in plants, lymphoblastic leukaemia, anti-miRNA oligonucleotides (AMOs), Kaposi, ’, s sarcoma-associated herpesvirus (KSHV), respiratory syncytial virus (RSV), parainfluenza virus (PIV)
Abstract: RNA silencing negatively regulates gene expression at transcriptional and posttranscriptional levels, guided by small RNA molecules. It modulates core regulatory pathways across the eukaryotes, such as developmental processes or stress responses. The widespread existence of this phenomenon and the key pathways regulated have led to the development of a new technology based on the modification of gene expression, which has been applied successfully in different areas such as medicine or agriculture. Here we review the most important patents related to RNA silencing across the life kingdoms, including biotechnological applications into medicine, crop science and bioengineering.
Export Options
About this article
Cite this article as:
Alvarez-Fernandez R., Lopez-Gomollon S., F. Lopez-Martinez A. and E. Nicolas F., Bioengineering RNA Silencing Across the Life Kingdoms, Recent Patents on Biotechnology 2011; 5 (2) . https://dx.doi.org/10.2174/187220811796365680
DOI https://dx.doi.org/10.2174/187220811796365680 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeted Therapies in Solid Tumours: Pinpointing the Tumours Achilles Heel
Current Pharmaceutical Design Human Immunodeficiency Virus (HIV) and Stroke: Targets for Intervention
Infectious Disorders - Drug Targets Vitamin D/VDR in Acute Kidney Injury: A Potential Therapeutic Target
Current Medicinal Chemistry Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
Current Drug Targets Adenosine Receptor Ligands in Clinical Trials
Current Topics in Medicinal Chemistry Common Pathways in Health Benefit Properties of RSV in Cardiovascular Diseases, Cancers and Degenerative Pathologies
Current Pharmaceutical Biotechnology Patent Selections:
Recent Patents on Drug Delivery & Formulation Electrotransfer into Skeletal Muscle for Protein Expression
Current Gene Therapy Parathyroid Hormone and Heart Failure: Novel Biomarker Strategy
Endocrine, Metabolic & Immune Disorders - Drug Targets Mitochondrial Alterations and Neuropsychiatric Disorders
Current Medicinal Chemistry Myocardial Regeneration: What is the Best Approach?
Current Cardiology Reviews Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection
Current Stem Cell Research & Therapy Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets Editorial:Circulating Biomarkers in Cardiovascular Diseases – A Field of Theoretical Research or Realistic Clinical Application?
Current Pharmaceutical Biotechnology The Therapeutic Potential of Hepatocyte Growth Factor for Myocardial Infarction and Heart Failure
Current Pharmaceutical Design Co-Enzyme Q10 to Treat Neurological Disorders: Basic Mechanisms, Clinical Outcomes, and Future Research Direction
CNS & Neurological Disorders - Drug Targets Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research
Current Pharmaceutical Design Multiple Sclerosis – Established and Novel Therapeutic Approaches
Central Nervous System Agents in Medicinal Chemistry Diabetes Mellitus: Channeling Care through Cellular Discovery
Current Neurovascular Research Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS)
Current Cancer Therapy Reviews